News GSK lawyer is indicted on charges of obstructing FDA proceeding BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c6570 (Published 17 November 2010) Cite this as: BMJ 2010;341:c6570 Article Related content Metrics Responses Peer review Related articles News GSK lawyer accused of off-label promotion has case dismissed Published: 16 May 2011; BMJ 342 doi:10.1136/bmj.d3060 See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362
